Novartis “At An Inflection Point,” Announces $5B BuybackVW Staff
In a move that reinforces its commitment to enhance returns to shareholders, Novartis AG (ADR) (NYSE:NVS) announced it will buy back shares worth $5B over the next two years, commencing immediately.
Novartis has reached an inflection point
"Novartis AG (ADR) (NYSE:NVS) has reached an inflection point, having fully integrated Alcon and reduced debt," said . . .
This content is exclusively for paying members. Sign up here
If you are subscribed and having an account error please clear cache and cookies if that does not work email email@example.com or click chat